Literature DB >> 175674

Irradiation of endometrial cancer in patients with medical contraindication to surgery or with unresectable lesions.

R C Landgren, G H Fletcher, L Delclos, J T Wharton.   

Abstract

In 124 medically inoperable patients with endometrial cancer, the five and ten year actuarial survival rates were 68% and 57%. In 26 patients with technically unresectable endometrial cancer, 26% actuarial survival rates at both five and ten years were seen. Pelvic control at death was 89% in Stage Ia, 78% in Stage Ib, 82% in Stage II, and 62% in Stage III. Sophisticated intracavitary therapy alone or in conjunction with external irradiation appears to give better uterine control rates than does external irradiation alone.

Entities:  

Mesh:

Year:  1976        PMID: 175674     DOI: 10.2214/ajr.126.1.148

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  The application of preoperative radiation therapy for unresectable malignancies.

Authors:  E Ashayeri; J Smyles; T Calhoun; E T Carreno; N Hagler
Journal:  J Natl Med Assoc       Date:  1988-08       Impact factor: 1.798

2.  Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients.

Authors:  Reiko Numazaki; Etsuko Miyagi; Katsuyuki Konnai; Masae Ikeda; Akihito Yamamoto; Ryo Onose; Hisamori Kato; Naoyuki Okamoto; Fumiki Hirahara; Hiroki Nakayama
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.